To Predict the Requirement of Pharmacotherapy by OGTT Glucose Levels in Women with GDM Classified by the IADPSG Criteria

Figure 1

ROC curves for prediction of initiation of pharmacotherapy by OGTT glucose measurements at fasting (a), 60′ (b), and 120′ (c) after oral glucose load; combined information of OGTT glucose measurements (d); clinical predictors (age, pregestational BMI, parity, history of GDM, family history with type 2 diabetes, and time of diagnosis) (e); and OGTT glucose measurements and clinical predictors (f).

(a)

(b)

(c)

(d)

(e)

(f)